IXHL

Incannex Healthcare Limited IXHL

IXHL
Incannex Healthcare Limited ZYBT
Zhengye Biotechnology Holding Limited STSS
Sharps Technology, Inc. AGEN
Agenus Inc. LUCD
Lucid Diagnostics Inc. SCLX
Scilex Holding Company CGTX
Cognition Therapeutics, Inc. SEER
Seer, Inc. SXTC
China SXT Pharmaceuticals, Inc. IRD
Opus Genetics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IXHL ZYBT STSS AGEN LUCD SCLX CGTX SEER SXTC IRD
6M 89.76 % -72.70 % -57.07 % -27.14 % -11.51 % 236.12 % 401.55 % -8.66 % -6.68 % 130.53 %
YTD -80.45 % -59.67 % -99.64 % 21.20 % 40.43 % 5.44 % 123.34 % -20.82 % -58.60 % 72.22 %
1Y -79.22 % -59.67 % -99.64 % 32.33 % 38.20 % -8.83 % 258.09 % -25.60 % -44.71 % 117.00 %
3Y -87.89 % -59.67 % -99.97 % -92.17 % -30.75 % -85.85 % -39.96 % -70.53 % -98.59 % 68.22 %
5Y -97.35 % -59.67 % -99.98 % -94.81 % -90.52 % -95.33 % -87.35 % -97.30 % -99.97 % 68.22 %
10Y -97.35 % -59.67 % -99.98 % -95.89 % -90.52 % -95.33 % -87.35 % -96.73 % -100.00 % 68.22 %
From the beginning -97.35 % -59.67 % -99.98 % -99.95 % -90.52 % -95.33 % -87.35 % -96.73 % -100.00 % 68.22 %

Dividend